Alendronate Sodium Tablets

Contract SPE2D2-26-D-0009 is a firm-fixed-price award issued by DLA Troop Support to Exelan Pharmaceuticals, Inc. for the supply of Alendronate Sodium tablets in 35mg and 70mg strengths. The contract has a total estimated value of 4,457,450.00 dollars, covering a five-year performance period consisting of a base year and three option years. The products are manufactured by Appco Pharma LLC in Piscataway, New Jersey, and packaged by Nutra-Med Packaging Inc. in Whippany, New Jersey. Deliveries are made FOB Destination to DLA and VA Pharmaceutical Prime Vendors, with labeling requiring specific National Drug Codes for both dosage strengths. The award was determined based on the Lowest Price Technically Acceptable (LPTA) basis. Exelan Pharmaceuticals, Inc., a small business with multiple socioeconomic designations including HubZone, SDVOSB, WOSB, and 8(a) certifications, is responsible for compliance with extensive FAR and DFARS regulations. Key requirements include strict supply chain security protocols, adherence to service contract labor standards, and prohibitions on certain foreign telecommunications and software entities. The contract includes detailed pricing schedules for blister packs of four tablets, with unit prices set at 2.00 dollars per box for both the 35mg and 70mg variants.